Native and genetically engineered anti-disialoganglioside monoclonal antibody treatment of melanoma.
Albertini
Mark R
MR
University of Wisconsin Comprehensive Cancer Center, Madison, WI 53792, USA. mralbert@facstaff.wisc.edu
Hank
Jacquelyn A
JA
Sondel
Paul M
PM
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000912:Antibodies, Neoplasm / Q000276:immunology; D005732:Gangliosides / Q000276:immunology*; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use; D008545:Melanoma / Q000188:drug therapy* / Q000276:immunology*; D012878:Skin Neoplasms / Q000188:drug therapy / Q000276:immunology
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D005732:Gangliosides; D007376:Interleukin-2; C025447:sialogangliosides